E7 TCR-T Cell Immunotherapy for Human Papillomavirus (HPV) Associated Cancers — StellaPhase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.
Trial locations(3 sites)
United States
National Institutes of Health Clinical Center, Bethesda, Maryland Rutgers Cancer Institute, New Brunswick, New Jersey RWJBarnabas Health - Robert Wood Johnson University Hospital, New Brunswick, New Jersey Age range
18 Years and older
Last updated February 2026